Organic Process Research & Development 2004, 8, 948−951
Highly Enantioselective Acylation of rac-Alkyl Lactates Using Candida
antarctica Lipase B
Yeon Soo Lee,* Joo Hee Hong, Nan Young Jeon, Keehoon Won, and Bum Tae Kim
Korea Research Institute of Chemical Technology, 100 Jangdong, Yuseonggu, Daejon 305-343, South Korea
Abstract:
derivatives with lipases have been reported,5,6 but the
substrate concentration and purifying process were not good
enough for industrial applications.
By using Candida antarctica lipase B under mild conditions,
the highly enantioselective acylation of alkyl (R)-lactate from
racemic mixture with vinyl alkanoate has been accomplished.
In this research effects of the organic solvent, the alkyl chain
length of the alkyl lactates and of the vinyl alkanoates, and the
reaction temperature on the enantiomeric excess as well as the
reaction rate, were investigated. In all cases, only alkyl (R)-
lactate was stereoselectively acylated at >99.5% ee. The lipase-
catalyzed acylation rate of the alkyl lactates was affected by
the nature of the organic solvents, but showed no correlation
to log P of the solvent. The lipase-catalyzed acylation rate of
the alkyl lactates was enhanced by increasing the chain length
of the vinyl alkanoate from acetyl to butanoyl and by raising
the reaction temperature to 65 °C. Finally, the lipase-catalyzed
acylation and subsequent vacuum distillation successfully
provided both butyl (R)-O-butanoyllactate and butyl (S)-lactate
in excellent yields (48%) and enantioselectivities (>99.5% ee)
on a large scale. It is expected that the present method will
prove to be more efficient in achieving the chiral resolution of
racemic alkyl lactate than other conventional methods in terms
of environmental friendliness and simplicity.
In the present research, we describe the enantioselective
acylation of racemic alkyl lactates with vinyl alkanoates using
Novozym 435, which is an immobilized form of lipase B
from Candida antarctica (CALB) (Scheme 1). CALB was
used for the enantioselective acylation of lactic acid with
vinyl acetate in tert-butyl methyl ether but was found not to
be efficient in resolving lactic acid.5 Instead of lactic acid,
we used alkyl lactates as an acyl acceptor. The effects of
the organic solvent, alkyl chain length of the alkyl lactates
and vinyl alkanoates, and the reaction temperature were
investigated briefly, and the large-scale enzymatic stereo-
selective acylation of butyl lactate was achieved without the
use of organic solvents.
Results and Discussion
First, as it is well-known that enzyme properties such as
activity and enantioselectivity can depend on the nature of
organic solvent in which the reaction is carried out, the effects
of the organic solvent were investigated. Among the many
physical parameters of organic solvents, log P value, which
is the logarithm of the partition coefficient of the solvent
between octanol and water, has been used for correlating
enzyme properties of a solvent nature.7,8 The lipase-catalyzed
acylation of ethyl lactate (R1 ) ethyl) with vinyl propionate
or butanoate (R2 ) ethyl or propyl) was conducted in a
variety of organic solvents at 25 °C. The conversion and
enantiomeric excess of (S)-1 and (R)-2 are shown at a
reaction time of 26 h, in Table 1. Log P values of the organic
solvents used, which were calculated using a hydrophobic
fragmental method developed by Rekker and de Kort,9 are
also described in ascending order in Table 1. Only the ethyl
(R)-lactates were stereoselectively acylated by the Novozym
435 in all the tested solvents. This is in accord with the
empirical rule established by Kazlauskas et al..6 This
empirical rule predicts which enantiomer will react the fastest
by comparing the size of the substituents at the chiral center
of secondary alcohols. The enantioselectivity was found to
Introduction
Lactic acid (2-hydroxypropionic acid) is a naturally
occurring organic acid and one of the simplest optically
active compounds having (R)- and (S)-optical isomers as
enantiomers. Optically pure (R)- and (S)-lactic acid deriva-
tives are used as a starting material for chiral drugs1 and
chiral polylactic acids.2 Whereas (S)-lactic acid is com-
mercially produced today through the microbial fermentation
of glucose, (R)-lactic acid is difficult to obtain. There are
two major methods to produce (R)-lactic acid production:
kinetic resolution of a racemic mixture3 and the direct
cultivation of microorganisms producing (R)-lactic acid.4
Due to their excellent chiral recognition, lipases have long
been used to achieve kinetic resolution of chiral alcohol or
carboxylic acid. Lactic acid possesses both a chiral alcohol
and a chiral carboxylic acid group, which can be resolved
by lipases. Several attempts to resolve racemic lactic acid
(5) Adam, W.; Lazarus, M.; Schmerder, A.; Humpf, H.-U.; Saha-Mo¨ller, C.
R.; Schreier, P. Eur. J. Org. Chem. 1998, 2013.
(6) Kazlauskas, R. J.; Weissfloch, A. N. E.; Rappaport, A. T.; Cuccia, L. A.
J. Org. Chem. 1991, 56, 2656.
(7) Chaudhary, A. K.; Kamat, S. V.; Beckman, E. J.; Nurok, D.; Kleyle, R.
M.; Hajdu, P.; Russell, A. J. J. Am. Chem. Soc. 1996, 118, 12891.
(8) Laane, C.; Boeren, S.; Vos, K.; Veeger, C. Biotechnol. Bioeng. 1987, 30,
81.
* Corresponding author. Telephone: +82-42-860-7154. Fax: +82-42-861-
(1) Kitazaki, T.; Tasaka, A.; Hosono, H.; Matsushita, Y.; Itoh, K. Chem. Pharm.
Bull. 1999, 47, 360.
(2) Murdoch, J. R.; Loomis, G. L. U.S. Patent 4,719,246, 1988.
(3) Hsieh, C.-L.; Houng, J.-Y. U.S. Patent 5,605,833, 1997.
(4) Cooper, B.; Kuesters, W.; Martin, C.; Siegel, H. U.S. Patent 4,769,329,
1988.
(9) Rekker, R. F.; de Kort, H. M. Eur. J. Med. Chem. 1979, 14, 479.
948
•
Vol. 8, No. 6, 2004 / Organic Process Research & Development
10.1021/op0498722 CCC: $27.50 © 2004 American Chemical Society
Published on Web 09/17/2004